IBB
iShares Biotechnology ETF
Price Chart
Latest Quote
$209.05
+0.10 (+0.05%)
Current Price
| Previous Close | $208.95 |
| Open | $207.24 |
| Day High | $209.84 |
| Day Low | $206.11 |
| Volume | 1,221,698 |
Fund Information
| Quarterly Dividend / Yield | N/A / 0.22% |
| Net Assets | $9.21B |
| Expense Ratio | 0.44% |
| Category | Health |
| Fund Family | iShares |
| Net Asset Value | $214.76 |
| Premium/Discount | -2.66% |
| Quarterly Dividend Yield | 0.22% |
| P/E Ratio | 27.12 |
| Exchange | NGM |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $204.71 |
| SMA50 | $195.28 |
| SMA200 | $176.48 |
| RSI | 60.71 |
| ATR | 4.5793 |
| Rel Volume | 0.77 |
Performance History
| Week | -1.64% |
| Month | +12.15% |
| Quarter | +23.45% |
| 6 Months | +20.30% |
| YTD | +23.81% |
| Year | +51.64% |
| 3 Years | +66.17% |
| 5 Years | +23.21% |
| 10 Years | +128.64% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-08-31 | $209.05 | 1,221,698 |
| 2026-08-28 | $208.95 | 1,420,500 |
| 2026-08-27 | $214.80 | 1,271,700 |
| 2026-08-26 | $215.23 | 1,390,600 |
| 2026-08-25 | $216.40 | 1,466,000 |
| 2026-08-24 | $212.53 | 1,243,100 |
| 2026-08-21 | $213.56 | 2,681,200 |
| 2026-08-20 | $210.83 | 2,785,500 |
| 2026-08-19 | $216.96 | 2,402,200 |
| 2026-08-18 | $203.56 | 1,535,000 |
| 2026-08-17 | $201.93 | 1,104,500 |
| 2026-08-14 | $198.26 | 583,400 |
| 2026-08-13 | $198.94 | 1,298,300 |
| 2026-08-12 | $200.72 | 1,779,700 |
| 2026-08-11 | $199.74 | 1,647,600 |
| 2026-08-10 | $200.02 | 1,900,200 |
| 2026-08-07 | $197.71 | 1,526,200 |
| 2026-08-06 | $192.97 | 1,998,300 |
| 2026-08-05 | $191.80 | 1,155,200 |
| 2026-08-04 | $190.15 | 1,146,200 |
| 2026-08-03 | $185.91 | 1,361,200 |
About iShares Biotechnology ETF
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
📰 Latest News
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Monday as US, Iran Exchange Attacks
MT Newswires • 2026-08-31T13:28:01ZIs iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
Zacks • 2026-08-31T10:20:02Z
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Friday Ahead of Warsh Speech
MT Newswires • 2026-08-28T12:43:48ZExchange-Traded Funds Higher, Equity Futures Mixed Pre-Bell Thursday Ahead of Fed's Jackson Hole Symposium
MT Newswires • 2026-08-27T13:16:00ZModerna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips
24/7 Wall St. • 2026-08-26T15:25:38Z
Exchange-Traded Funds Lower, Equity Futures Mixed Pre-Bell Wednesday Amid Inflation Data Release
MT Newswires • 2026-08-26T13:12:26ZMerck Just Gained 19% in a Month. What Would It Take to Get MRK Stock Up to $200?
24/7 Wall St. • 2026-08-25T19:51:36Z
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Tuesday as Chip Stocks Recover
MT Newswires • 2026-08-25T13:09:24ZModerna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips
24/7 Wall St. • 2026-08-24T15:34:00Z
Why Regenxbio Halted Its Gene Therapy Trial—and Why the Stock Is Tumbling
Barrons.com • 2026-08-24T14:18:00Z
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.